Table 3.
Time-Varying Exposure | Cancer N = 100 |
Advanced Dementia N = 108 |
Organ Failure N = 114 |
Frailty N = 167 |
Other Condition N = 73 |
---|---|---|---|---|---|
Adjusted Hazard Ratio (95% CI) a | |||||
Specific month b | |||||
Any restricting symptoms | 2.72 (1.56–4.75) | 1.31 (0.81–2.14) | 2.03 (1.13–3.67) | 1.53 (0.83–2.83) | 1.50 (0.59–3.82) |
Per no. restricting symptoms c | 1.16 (1.05–1.27) | 1.05 (0.97–1.13) | 1.07 (0.99–1.15) | 1.11 (1.01–1.23) | 1.14 (0.98–1.33) |
Per no. disabilities d | 1.12 (1.04–1.21) | 1.05 (0.89–1.24) | 1.13 (1.00–1.29) | 1.21 (1.06–1.38) | 1.21 (1.01–1.44) |
Cumulative number of months e | |||||
Any restricting symptoms | 1.06 (0.94–1.20) | 0.94 (0.84–1.05) | 1.17 (1.01–1.37) | 1.14 (0.98–1.33) | 1.08 (0.92–1.27) |
Abbreviation: CI, confidence interval.
Covariates included age, sex, race/ethnicity, years of education, living situation, number of chronic conditions, cognitive impairment, depressive symptoms, low social support and months since prior comprehensive assessment.
Results reflect the marginal (i.e. average) effect of each exposure at month t-1 on hospice admission at month t.
Possible range: 0 to 15
Possible range: 0 to 13
Results reflect the effect of each additional month with any restricting symptoms as a time-varying exposure (up to month t-1) on hospice admission at month t.